BPC-157 vs GHK-Cu

BPC-157 and GHK-Cu are both studied in connective-tissue, angiogenesis, and fibroblast research — but they are unrelated compounds with different mechanisms. BPC-157 is a synthetic pentadecapeptide acting on NO/eNOS and VEGFR2 pathways; GHK-Cu is a naturally occurring copper-chelating tripeptide modulating collagen synthesis, MMP/TIMP balance, and Nrf2 antioxidant response.

By HALO Editorial · Reviewed June 12, 2026 · Editorial standards

Short answer

Research-context summary: Complementary, not interchangeable. BPC-157 for vascular/NO/VEGFR2 and tendon-ligament research; GHK-Cu for fibroblast ECM, collagen synthesis, and copper-biology models. Combination studies are valid when the goal is additive connective-tissue effects — attribute each mechanism separately.

Use limitation: HALO comparison pages are for research context only; both materials are RUO and not for human or veterinary use.

	BPC-157	GHK-Cu
Class	Synthetic pentadecapeptide (gastric-protein derived)	Copper tripeptide complex (Gly-His-Lys + Cu²⁺)
CAS	137525-51-0	89030-95-5
Molecular weight	1,419.56 g/mol	340.38 g/mol (free peptide)
Primary mechanism	NO/eNOS/cGMP + VEGFR2 → ERK1/2, PI3K-Akt; EGR-1 transcription	Collagen/ECM synthesis, MMP/TIMP balance, VEGF/HIF-1α, Nrf2/ARE
Key research models	Tendon/ligament, vascular endothelium, gastric mucosa	Fibroblast, keratinocyte, endothelial cultures
Angiogenesis pathway	VEGFR2 phosphorylation → ERK/PI3K	VEGF upregulation via HIF-1α
Format note	Lyophilized white powder	Lyophilized light-blue powder (Cu²⁺ chromophore)
Available sizes	2 mg · 5 mg · 10 mg	50 mg · 100 mg

Different families, overlapping research territory

Both compounds appear in connective-tissue and wound-healing research literature, which creates frequent comparison — but they are unrelated molecules with non-overlapping primary mechanisms. BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric protein fragment; GHK-Cu is a 3-amino-acid copper complex first isolated from human plasma. Treating them as interchangeable in a research protocol would confound results.

BPC-157 — vascular and NO signalling

BPC-157’s best-characterised pathway is the endothelial NO synthase / VEGFR2 axis: upregulating eNOS expression, stimulating NO-dependent vasodilation, and phosphorylating VEGFR2 to drive ERK1/2 and PI3K-Akt downstream. A secondary axis involves EGR-1 transcription factor activation, promoting PDGF, VEGF, and FGF expression in connective-tissue models. BPC-157 research spans tendon/ligament cultures, vascular endothelial models, and gastric mucosa systems.

GHK-Cu — ECM remodelling and copper biology

GHK-Cu acts primarily on extracellular-matrix biology in fibroblast and keratinocyte cultures: upregulating collagen type-I, elastin, and fibronectin synthesis; modulating the MMP/TIMP protease/inhibitor balance toward net ECM deposition; and activating the Nrf2/ARE antioxidant response. Its angiogenic effects flow through VEGF upregulation via HIF-1α rather than direct VEGFR2 phosphorylation. The copper coordination is structurally essential — GHK without Cu²⁺ does not reproduce the same signalling profile.

When to run them together

Because their upstream entry points differ (VEGFR2/eNOS vs collagen/MMP/Nrf2) but both influence angiogenesis and connective-tissue endpoints, preclinical protocols sometimes combine them to study additive ECM and vascular effects. The shared downstream node (Akt activation in some models) makes combination studies experimentally informative, but the mechanisms should be attributed separately. See also BPC-157 vs TB-500 for the actin-binding comparator in the same research space.

Identity and handling

Both ship at ≥98% HPLC purity with independent COA. BPC-157 reconstitutes in sterile bacteriostatic water; GHK-Cu reconstitutes in water or dilute acetic acid and should be stored away from EDTA (which chelates Cu²⁺). Both store −20 °C lyophilized, 4 °C reconstituted ≤28 days. GHK-Cu’s light-blue colour is a Cu²⁺ chromophore — not a purity indicator.

Common comparison questions

Are BPC-157 and GHK-Cu the same type of compound?

No. BPC-157 is a 15-amino-acid synthetic peptide; GHK-Cu is a 3-amino-acid copper tripeptide complex. They target different signalling pathways despite both being studied in connective-tissue research.

Which is better for fibroblast culture research?

GHK-Cu has more direct fibroblast/ECM literature — collagen synthesis, MMP/TIMP balance, and Nrf2 activation in fibroblast models. BPC-157 is more characterised in vascular endothelial and tendon/ligament systems, though both appear in connective-tissue research.

Do they share any signalling pathways?

Both can influence angiogenesis-related endpoints, but through different upstream mechanisms: BPC-157 via VEGFR2/eNOS, GHK-Cu via VEGF/HIF-1α and ECM remodelling. Akt activation appears as a shared downstream node in some models.

Why is GHK-Cu blue?

The light-blue colour comes from the square-planar Cu²⁺ coordination complex — a chromophore, not a contamination indicator. Reconstituted solutions may appear blue-green depending on concentration and pH.

Research use only. Both compounds are sold by HALO for in vitro and qualified laboratory research only. Not for human or veterinary use, diagnosis, or treatment.